Appili Therapeutics Stock Market Outlook
| APLI Stock | CAD 0.02 0.01 20.00% |
About 61% of Appili Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Appili Therapeutics suggests that many traders are alarmed. Appili Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Appili Therapeutics. Many technical investors use Appili Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 39
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Appili Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Appili Therapeutics.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Appili Therapeutics is 'Strong Sell'. The recommendation algorithm takes into account all of Appili Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
Execute Appili Therapeutics Advice
The Appili recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Appili Therapeutics. Macroaxis does not own or have any residual interests in Appili Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Appili Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Mild | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
For the selected time horizon Appili Therapeutics has a Mean Deviation of 9.32, Semi Deviation of 9.83, Standard Deviation of 14.1, Variance of 198.72, Downside Variance of 423.15 and Semi Variance of 96.67We provide trade advice to complement the prevailing expert consensus on Appili Therapeutics. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Appili Therapeutics is not overpriced, please confirm all Appili Therapeutics fundamentals, including its price to book, revenue, and the relationship between the number of shares shorted and price to sales .
Appili Therapeutics Trading Alerts and Improvement Suggestions
| Appili Therapeutics is way too risky over 90 days horizon | |
| Appili Therapeutics has some characteristics of a very speculative penny stock | |
| Appili Therapeutics appears to be risky and price may revert if volatility continues | |
| Appili Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 100.44 K. Net Loss for the year was (2.62 M) with profit before overhead, payroll, taxes, and interest of 100.44 K. | |
| Latest headline from news.google.com: Appili Deepens Non-Dilutive Funding Base as Infectious Disease Pipeline Advances - TipRanks |
Appili Therapeutics Returns Distribution Density
The distribution of Appili Therapeutics' historical returns is an attempt to chart the uncertainty of Appili Therapeutics' future price movements. The chart of the probability distribution of Appili Therapeutics daily returns describes the distribution of returns around its average expected value. We use Appili Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Appili Therapeutics returns is essential to provide solid investment analysis for Appili Therapeutics.
| Mean Return | 0.96 | Value At Risk | -20 | Potential Upside | 25.00 | Standard Deviation | 14.10 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Appili Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Appili Therapeutics Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Investments | 5.1M | (3.2K) | (29.1K) | (2.4K) | (2.7K) | (2.8K) | |
| Change In Cash | (4.4M) | (4.2M) | (2.4M) | 1.1M | 1.0M | 1.1M | |
| Net Borrowings | 3.8M | 2.4M | 203.6K | 258.2K | 296.9K | 282.1K | |
| Free Cash Flow | (19.1M) | (10.1M) | (2.5M) | 866.5K | 779.8K | 818.8K | |
| Depreciation | 12.6K | 6.3K | 13.7K | 13.5K | 12.1K | 11.3K | |
| Other Non Cash Items | 1.6M | 1.1M | 450.0K | 3.6M | 4.1M | 4.3M | |
| Capital Expenditures | 2.1K | 3.2K | 29.7K | 2.4K | 2.1K | 2.0K | |
| Net Income | (25.1M) | (9.2M) | (3.8M) | (2.6M) | (2.4M) | (2.5M) | |
| End Period Cash Flow | 6.7M | 2.5M | 94.5K | 1.2M | 1.1M | 1.1M |
Appili Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Appili Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Appili Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Appili stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.95 | |
β | Beta against Dow Jones | -0.09 | |
σ | Overall volatility | 13.47 | |
Ir | Information ratio | 0.06 |
Appili Therapeutics Volatility Alert
Appili Therapeutics is showing large volatility of returns over the selected time horizon. Appili Therapeutics is a penny stock. Although Appili Therapeutics may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Appili Therapeutics. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Appili instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Appili Therapeutics Fundamentals Vs Peers
Comparing Appili Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Appili Therapeutics' direct or indirect competition across all of the common fundamentals between Appili Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Appili Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Appili Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Appili Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Appili Therapeutics to competition |
| Fundamentals | Appili Therapeutics | Peer Average |
| Return On Equity | -9.39 | -0.31 |
| Return On Asset | -2.69 | -0.14 |
| Operating Margin | (88.64) % | (5.51) % |
| Current Valuation | 14.3 M | 16.62 B |
| Shares Outstanding | 121.27 M | 571.82 M |
| Shares Owned By Insiders | 0.06 % | 10.09 % |
| Shares Owned By Institutions | 11.84 % | 39.21 % |
| Number Of Shares Shorted | 5.98 K | 4.71 M |
| Price To Book | 1.40 X | 9.51 X |
| Price To Sales | 11.76 X | 11.42 X |
| Revenue | 100.44 K | 9.43 B |
| Gross Profit | 100.44 K | 27.38 B |
| EBITDA | 360.57 K | 3.9 B |
| Net Income | (2.62 M) | 570.98 M |
| Cash And Equivalents | 5.55 M | 2.7 B |
| Cash Per Share | 0.05 X | 5.01 X |
| Total Debt | 12.29 M | 5.32 B |
| Current Ratio | 1.99 X | 2.16 X |
| Book Value Per Share | (0.12) X | 1.93 K |
| Cash Flow From Operations | 868.82 K | 971.22 M |
| Short Ratio | 0.01 X | 4.00 X |
| Earnings Per Share | (0.02) X | 3.12 X |
| Target Price | 0.15 | |
| Number Of Employees | 7 | 18.84 K |
| Beta | 0.13 | -0.15 |
| Market Capitalization | 3.03 M | 19.03 B |
| Total Asset | 3.03 M | 29.47 B |
| Retained Earnings | (71.72 M) | 9.33 B |
| Working Capital | (12.68 M) | 1.48 B |
| Net Asset | 3.03 M |
Appili Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Appili . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Appili Therapeutics Buy or Sell Advice
When is the right time to buy or sell Appili Therapeutics? Buying financial instruments such as Appili Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Appili Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Materials ETFs Thematic Idea Now
Materials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 59 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Appili Stock
Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.